IP Library Assignment 074939/0717
Patent Assignment
Reel/Frame 074939/0717

Assignment of Assignor's Interest

Recorded: 2026-02-19 Pages: 34
Assignors
OXFORD FINANCE LLC
Executed: 2025-08-21
EFFECTOR THERAPEUTICS, INC.
Executed: 2025-08-21
Assignee
SJP BIOTEC GMBH
SEESTRASSE 880, MEILEN, ZURICH, 8706, SWITZERLAND
Covered Properties (24)
EIF4A-Inhibiting Compounds and Methods Related Thereto
Application: 17/720,529 →
Publication: US 2023/0071483
EIF4A-Inhibiting Compounds and Methods Related Thereto
Application: 18/324,616 →
Publication: US 2023/0295179
EIF4E-Inhibiting Compounds and Methods
Application: 17/587,185 →
Publication: US 2023/0108594
Methods and Compositions for Cellular Immunotherapy
Application: 18/158,770 →
Publication: US 2023/0381232
Mnk Inhibitors and Methods Related Thereto
Patent: 9,382,248 →
Application: 14/748,990 →
Publication: US 2015/0376181
Mnk Inhibitors and Methods Related Thereto
Patent: 9,669,031 →
Application: 15/187,854 →
Publication: US 2016/0317536
Mnk Inhibitors and Methods Related Thereto
Patent: 9,814,718 →
Application: 15/611,966 →
Publication: US 2017/0266185
Isoindoline, Azaisoindoline, Dihydroindenone and Dihydroazaindenone Inhibitors of MNK1 and MNK2
Application: 15/337,184 →
Publication: US 2017/0121346
Pyrrolo-, Pyrazolo-, Imidazo-Pyrimidine and Pyridine Compounds That Inhibit MNK1 and MNK2
Application: 16/378,809 →
Publication: US 2019/0330216
Heterocyclic Compounds That Inhibit the Kinase Activity of Mnk Useful for Treating Various Cancers
Application: 15/355,271 →
Publication: US 2017/0145009
EIF4A-Inhibiting Compounds and Methods Related Thereto
Patent: 9,957,277 →
Application: 15/358,761 →
Publication: US 2017/0145026
EIF4A-Inhibiting Compounds and Methods Related Thereto
Application: 15/917,973 →
Publication: US 2018/0298017
EIF4A-Inhibiting Compounds and Methods Related Thereto
Application: 16/804,937 →
Publication: US 2020/0339590
Piperidine-Substituted Mnk Inhibitors and Methods Related Thereto
Application: 16/233,507 →
Publication: US 2019/0275039
Piperidine-Substituted Mnk Inhibitors and Methods Related Thereto
Application: 17/396,187 →
Publication: US 2022/0096472
Benzimidazole-Indole Inhibitors of MNK1 and MNK2
Application: 16/162,459 →
Publication: US 2019/0119256
Crystalline Forms of Mnk Inhibitors
Application: 16/661,507 →
Publication: US 2020/0131179
Crystalline Forms of Mnk Inhibitors
Application: 17/484,564 →
Publication: US 2022/0119387
Compositions and Methods for Treating Fibrotic Disease
Patent: 9,993,494 →
Application: 14/616,690 →
Publication: US 2015/0224132
Compositions and Methods for Treating Fibrotic Disease
Application: 15/973,281 →
Publication: US 2019/0038657
Inhibitors of Immune Checkpoint Modulators and Related Methods
Application: 15/130,538 →
Publication: US 2016/0303124
Methods and Compositions for Cellular Immunotherapy
Application: 15/989,098 →
Publication: US 2018/0353545
Methods and Compositions for Cellular Immunotherapy
Application: 17/025,607 →
Publication: US 2021/0177898
Compositions and Methods for an Improved Antitumor Immune Response
Application: 16/616,087 →
Publication: US 2020/0147135
Related Assignments (6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 4, 2015
From: REICH, SIEGFRIED H.; SPRENGELER, PAUL A.; XIANG, ALAN X.; ERNST, JUSTIN T.
To: EFFECTOR THERAPEUTICS, INC.
Reel/Frame 036496/0568 →
Assignment of Assignor's Interest Jan 22, 2018
From: ERNST, JUSTIN T.; REICH, SIEGFRIED H.; SPRENGELER, PAUL A.; TRAN, CHINH VIET
To: EFFECTOR THERAPEUTICS, INC.
Reel/Frame 045108/0821 →
Assignment of Assignor's Interest Jun 23, 2021
From: REICH, SIEGFRIED H.; SPRENGELER, PAUL A.; WEBBER, STEPHEN E.; XIANG, ALAN X.
To: EFFECTOR THERAPEUTICS, INC.
Reel/Frame 056639/0445 →
Assignment of Assignor's Interest Feb 28, 2024
From: REICH, SIEGFRIED H.; SPRENGELER, PAUL A.; WEBBER, STEPHEN E.; XIANG, ALAN X.
To: EFFECTOR THERAPEUTICS, INC.
Reel/Frame 066588/0377 →
Security Interest Jul 25, 2024
From: EFFECTOR THERAPEUTICS, INC.
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 068086/0538 →
Assignment of Assignor's Interest Feb 26, 2026
From: ERNST, JUSTIN T.; REICH, SIEGFRIED H.; SPRENGELER, PAUL A.; TRAN, CHINH VIET
To: EFFECTOR THERAPEUTICS, INC.
Reel/Frame 073902/0270 →